{"groups":[{"description":"Thalidomide 400 QD during induction, 100 mg QD between transplants, 200 mg QD post transplant, 100 mg QD during year one of maintenance, and 50 mg QD during second year of maintenance.","id":"FG000","title":"Thalidomide"},{"description":"Patient received no thalidomide during induction, consolidation, and maintenance therapy.","id":"FG001","title":"No Thalidomide"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"323"},{"groupId":"FG001","numSubjects":"345"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"323"},{"groupId":"FG001","numSubjects":"345"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}